Lake Street Maintains Buy on TELA Bio, Lowers Price Target to $2

Benzinga Newsdesk www.benzinga.com Neutral 56.3%

Neg 0% Neu 56.3% Pos 0%

Lake Street analyst Frank Takkinen maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $3 to $2.